as on December 5, 2025 at 2:24 am IST
Day's Low
Day's High
7.26%
Downside
4.03%
Upside
52 Week's Low
52 Week's High
65.68%
Downside
9.88%
Upside
Check Pacific Biosciences Of California, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$733.6M
EPS (TTM)
-0.539
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.93
Industry PE ratio
-0.4116938110749186
PEG Ratio
-0.17
EBITDA
-192.6M
Revenue (TTM)
154.6M
Profit Margin
0.00%
Return On Equity TTM
-205.90%
Track how Pacific Biosciences Of California, Inc. P/E has moved over time to understand its valuation trends.
Pacific Biosciences Of California, Inc. in the last 5 years
Lowest (-130.72x)
December 31, 2020
Today (-0.93x)
December 5, 2025
Industry (-0.41x)
December 5, 2025
Highest (-1.16x)
September 30, 2024
Today’s Price to Earnings Ratio: -0.93x
Compare market cap, revenue, PE, and other key metrics of Pacific Biosciences Of California, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $733.6M | -87.69% | -0.93 | 0.00% | |
| BUY | $146.1B | 183.99% | 52.71 | 14.43% | |
| BUY | $139.9B | 52.07% | 48.09 | 12.07% | |
| BUY | $130.8B | -10.42% | 27.63 | 13.71% | |
| BUY | $218.1B | 16.22% | 15.88 | 31.88% |
The Pacific Biosciences Of California, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Pacific Biosciences Of California, Inc. investment value today
Current value as on today
₹1,31,409
Returns
₹31,409
(+31.41%)
Returns from Pacific Biosciences Of California, Inc. Stock
₹25,253 (+25.25%)
Dollar Returns*
₹6,157 (+6.16%)
Based on 20 analysts
55.00%
Buy
45.00%
Hold
0.00%
Sell
Based on 20 analysts, 55% of analysts recommend a 'BUY' rating for Pacific Biosciences Of California, Inc.. Average target price of $2.29
Get share price movements and forecasts by analysts on Pacific Biosciences Of California, Inc..
What analysts predicted
-8.3%DOWNSIDE
Target Price
$2.29
Current Price
$2.48
Analyzed by
20 Analysts
Target
$2.29
Pacific Biosciences Of California, Inc. target price $2.29, a slight downside of -8.3% compared to current price of $2.48. According to 20 analysts rating.
Investment in Pacific Biosciences Of California, Inc. Shares on INDmoney has grown by 3.22% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:3.22% versus previous 30 day period
Search interest for Pacific Biosciences Of California, Inc. Stock has increased by 164% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:164% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 08 October
Wed, 09:06 PM
-PACB shares jumped 9.3% after National Institute on Aging selected its technology for a major longevity study.
Wed, 10:14 PM
-PacBio announced expanded partnership with seqWell, but shares dipped nearly 7.9% following the news.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -426.07M → -38.0M (in $), with an average increase of 463.3% per quarter
Best in 1 Year
![]()
In the last 1 year, PACB has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 1 month, PACB stock has moved up by 29.8%
Against Peers
![]()
In the last 3 years, Boston Scientific Corp. has given 29.4% return, outperforming this stock by 104.6%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 39.76M → 38.44M (in $), with an average decrease of 3.3% per quarter
| Organisation | Pacific Biosciences Of California, Inc. |
| Headquarters | 1305 O?Brien Drive, Menlo Park, CA, United States, 94025 |
| Industry | Health Technology |
| CEO | Mr. Christian O. Henry M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Natalie Welch | Chief People Officer |
Mr. Christian O. Henry M.B.A. | President, CEO & Director |
Mr. Mark Van Oene Ph.D. | Chief Operating Officer |
Dr. Stephen Turner Ph.D. | Co-Founder |
Mr. James R. Gibson II | Chief Financial Officer |
Ms. Michele Farmer CPA | VP & Chief Accounting Officer |
Dr. Brett Atkins J.D., Ph.D. | General Counsel & Corporate Secretary |
Mr. David Ruggiero | Global Head of Sales & Service |
Pacific Biosciences Of California, Inc. share price today is $2.48 as on at the close of the market. Pacific Biosciences Of California, Inc. share today touched a day high of $2.58 and a low of $2.3.
Pacific Biosciences Of California, Inc. share touched a 52 week high of $2.73 on and a 52 week low of $0.85 on . Pacific Biosciences Of California, Inc. stock price today i.e. is closed at $2.48,which is 8.99% down from its 52 week high and 191.39% up from its 52 week low.
Pacific Biosciences Of California, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Pacific Biosciences Of California, Inc. (PACB) shares with as little as ₹89.927 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹899.27 in Pacific Biosciences Of California, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Pacific Biosciences Of California, Inc. share’s latest price of $2.48 as on December 5, 2025 at 2:24 am IST, you will get 4.0323 shares of Pacific Biosciences Of California, Inc.. Learn more about
fractional shares .
Pacific Biosciences Of California, Inc. stock has given -87.69% share price returns and 21.87% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?